Worth Venture Partners, LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Worth Venture Partners, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2018 Feb 15, 2019	SELL	$10.36 - $20.96 $621,600 - $1.26 Million	-60,000 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$17.77 - $22.9 $515,330 - $664,100	-29,000 Reduced 32.58%	60,000 $207,000
Q2 2018 Aug 13, 2018	SELL	$17.33 - $23.4 $346,599 - $468,000	-20,000 Reduced 18.35%	89,000 $183,000
Q1 2018 May 25, 2018	SELL	$15.16 - $25.49 $164 Million - $275 Million	-10,791,000 Reduced 99.0%	109,000 $579,000
Q1 2018 May 11, 2018	BUY	$15.16 - $25.49 $165 Million - $277 Million	10,854,700 Added 23961.81%	10,900,000 $579,000
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $646,431 - $760,587	45,300	45,300 $105,000

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.